118 related articles for article (PubMed ID: 25859348)
1. Increased risk of death in African American patients with end-stage renal disease secondary to lupus.
Sule S; Fivush B; Neu A; Furth S
Clin Kidney J; 2014 Feb; 7(1):40-4. PubMed ID: 25859348
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of death in pediatric and adult patients with ESRD secondary to lupus.
Sule S; Fivush B; Neu A; Furth S
Pediatr Nephrol; 2011 Jan; 26(1):93-8. PubMed ID: 20890767
[TBL] [Abstract][Full Text] [Related]
3. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
[TBL] [Abstract][Full Text] [Related]
4. Increased hospitalizations and death in patients with ESRD secondary to lupus.
Sule S; Fivush B; Neu A; Furth S
Lupus; 2012 Oct; 21(11):1208-13. PubMed ID: 22736748
[TBL] [Abstract][Full Text] [Related]
5. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
[TBL] [Abstract][Full Text] [Related]
6. Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System.
Broder A; Mowrey WB; Izmirly P; Costenbader KH
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):599-604. PubMed ID: 27390299
[TBL] [Abstract][Full Text] [Related]
7. Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study.
Broder A; Mowrey WB; Kim M; Murakhovskaya I; Billett H; Neugarten J; Costenbader KH; Putterman C
Rheumatology (Oxford); 2016 May; 55(5):817-25. PubMed ID: 26705328
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.
Plantinga LC; Lim SS; Patzer RE; Pastan SO; Drenkard C
BMC Nephrol; 2016 Jul; 17(1):64. PubMed ID: 27388761
[TBL] [Abstract][Full Text] [Related]
9. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
[TBL] [Abstract][Full Text] [Related]
10. Infection-related hospitalization and risk of end-stage renal disease in patients with systemic lupus erythematosus: a nationwide population-based study.
Lin CH; Hung PH; Hu HY; Chen YJ; Guo HR; Hung KY
Nephrol Dial Transplant; 2017 Oct; 32(10):1683-1690. PubMed ID: 28011646
[TBL] [Abstract][Full Text] [Related]
11. Osteoporotic fractures in patients with systemic lupus erythematosus and end stage renal disease.
Le B; Waller JL; Radhakrishnan R; Oh SJ; Kheda MF; Nahman NS; Carbone L
Lupus; 2018 Jan; 27(1):17-24. PubMed ID: 28530467
[TBL] [Abstract][Full Text] [Related]
12. Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
Modi ZJ; Lu Y; Ji N; Kapke A; Selewski DT; Dietrich X; Abbott K; Nallamothu BK; Schaubel DE; Saran R; Gipson DS
JAMA Cardiol; 2019 Apr; 4(4):353-362. PubMed ID: 30892557
[TBL] [Abstract][Full Text] [Related]
13. Risk of End-Stage Renal Disease in Patients With Systemic Lupus Erythematosus and Diabetes Mellitus: A Danish Nationwide Cohort Study.
Hansen RB; Falasinnu T; Faurschou M; Jacobsen S; Simard JF
Arthritis Care Res (Hoboken); 2023 Sep; 75(9):1871-1877. PubMed ID: 36705445
[TBL] [Abstract][Full Text] [Related]
14. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.
Arriens C; Chen S; Karp DR; Saxena R; Sambandam K; Chakravarty E; James JA; Merrill JT
Clin Immunol; 2017 Dec; 185():3-9. PubMed ID: 27923701
[TBL] [Abstract][Full Text] [Related]
16. Methodological considerations in comparing access to Pre-emptive renal transplantation between SLE and other ESRD causes in the USRDS.
Broder A; Mowrey WB; Golestaneh L; Putterman C; Costenbader KH; Kim M
Semin Arthritis Rheum; 2019 Feb; 48(4):678-685. PubMed ID: 30064728
[TBL] [Abstract][Full Text] [Related]
17. Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry.
Plantinga LC; Drenkard C; Pastan SO; Lim SS
Lupus Sci Med; 2016; 3(1):e000132. PubMed ID: 26848398
[TBL] [Abstract][Full Text] [Related]
18. Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American pediatric renal transplant cooperative study.
Bartosh SM; Fine RN; Sullivan EK
Transplantation; 2001 Sep; 72(5):973-8. PubMed ID: 11571477
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis.
Gómez-Puerta JA; Feldman CH; Alarcón GS; Guan H; Winkelmayer WC; Costenbader KH
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1453-62. PubMed ID: 25624071
[TBL] [Abstract][Full Text] [Related]
20. Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus.
Barnado A; Carroll RJ; Casey C; Wheless L; Denny JC; Crofford LJ
Arthritis Res Ther; 2018 Apr; 20(1):69. PubMed ID: 29636090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
